An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing Sarcoma

Pediatric Blood and Cancer

Volumn 60, Issue 7, 2013, Pages 1113-1117

  Newman, Erik N ^a   Jones, Robin L ^a,b   Hawkins, Douglas S ^a,b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

Bone marrow; Bone marrow examination; Ewing sarcoma; Fluorodeoxyglucose F18; Neoplasm staging; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW BIOPSY; BONE METASTASIS; BONE SCINTISCANNING; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CHILD; CLINICAL EVALUATION; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; EWING SARCOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADULT; BIOPSY, NEEDLE; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SARCOMA, EWING; YOUNG ADULT;

EID: 84878262365     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24406     Document Type: Article

References (15)

1. Balamuth NJ, Womer RB. Ewing's sarcoma. Lancet Oncol 2010;11:184-192.
2. Ladenstein R, Pötschger U, Le Deley MC, et al. Primary disseminated multifocal ewing sarcoma: Results of the Euro-EWING 99 trial. J Clin Oncol 2010;28:3284-3291.
3. Völker T, Denecke T, Steffen I, et al. Positron emission tomography for staging of pediatric sarcoma patients: Results of a prospective multicenter trial. J Clin Oncol 2007;25:5435-5441.
4. Kumar J, Seith A, Kumar J, et al. Whole-body MR imaging with the use of parallel imaging for detection of skeletal metastases in pediatric patients with small-cell neoplasms: Comparison with skeletal scintigraphy and FDG PET/CT. Pediatr Radiol 2008;38:953-962.
5. Kneisl JS, Patt JC, Johnson JC, et al. Is PET useful in detecting occult nonpulmonary metastases in pediatric bone sarcomas? Clin Orthop Relat R 2006;450:101-104.
6. Györke T, Zajic T, Lange A, et al. Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours. Nucl Med Commun 2006;27:17-24.
7. Franzius C, Sciuk J, Daldrup-Link HE, et al. FDG-PET for detection of osseous metastases from malignant primary bone tumours: Comparison with bone scintigraphy. Eur J Nucl Med 2000;27:1305.
8. 18F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: A systematic review and a meta-analysis. Skeletal Radiol 2012;41:249-256.
9. Mazumdar A, Siegel MJ, Narra V, et al. Whole-body fast inversion recovery MR imaging of small cell neoplasms in pediatric patients: A pilot study. Am J Roentgenol 2002;179:1261-1266.
10. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Bone Cancer. http://www.nccn.org/professionals/physician_gls/pdf/bone.pdf. Published January 18, 2012. Accessed July 10, 2012.
11. Meyer JS, Nadel HR, Marina N, et al. Imaging guidelines for children with Ewing sarcoma and osteosarcoma: A report from the Children's Oncology Group Bone Tumor Committee. Pediatr Blood Cancer 2008;51:163-170.
12. Eary J, Mankoff D. Tumor metabolic rates in sarcoma using FDG PET. J Nucl Med 1998;39:250-254.
13. Wang J, Weiss LM, Chang KL, et al. Diagnostic utility of bilateral bone marrow examination: Significance of morphologic and ancillary technique study in malignancy. Cancer 2002;94:1522-1531.
14. Oberlin O, Bayle C, Hartmann O, et al. Incidence of bone marrow involvement in Ewing's sarcoma: Value of extensive investigation of the bone marrow. Med Pediatr Oncol 1995;24:343-346.
15. Dubois SG, Epling CL, Teague J, et al. Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow. Pediatr Blood Cancer 2010;54:13-18.